Showing 561 - 580 results of 761 for search '"placebo"', query time: 0.08s Refine Results
  1. 561

    Still No Substantial Evidence to Use Prophylactic Antibiotic at Operative Vaginal Delivery: Systematic Review and Meta-Analysis by Yifru Berhan, Sisay Kirba, Achamyelesh Gebre

    Published 2020-01-01
    “…In the included randomized trial, 97% of the study participants had perineal wound for whom repairs were performed; the risks of maternal infection and perineal wound breakdown were comparable, and maternal infections other than perineal wound infection did not show significant difference between prophylactic antibiotic and placebo groups. The majority of included studies demonstrated a strong association of postpartum infection and perineal wound dehiscence with episiotomy and perineal tear. …”
    Get full text
    Article
  2. 562

    Tolerability of Capsaicinoids from Capsicum Extract in a Beadlet Form: A Pilot Study by Jayant Deshpande, Shankaranarayanan Jeyakodi, Vijaya Juturu

    Published 2016-01-01
    “…The study was to evaluate the safety and tolerability of the capsaicinoids (CAPs) from Capsicum extract in a beadlet form compared to placebo in a healthy overweight population. The investigational product capsaicinoids (CAPs) from Capsicum extract in a beadlet form (Capsimax®) a proprietary encapsulated form of Capsicum extract in beadlet form supplemented at 2 mg, 4 mg, 6 mg, 8 mg and 10 mg of CAPs. …”
    Get full text
    Article
  3. 563

    Management of hepatorenal syndrome and associated outcomes: a systematic review by Anahid Hamidianjahromi, Jamshid Roozbeh, Shahrokh Ezzatzadegan Jahromi, Mohamad Hossein Rezazadeh, Leila Malekmakan

    Published 2024-04-01
    “…Of which 24 articles were conducted on terlipressin versus placebo or other treatments (midodrine/octreotide, norepinephrine, etc) that showed the higher rate of HRS reversal was detected for terlipressin in 17 studies (10 of them were significant), 2 studies achieved an insignificant lower rate of the model for end-stage liver disease score for terlipressin, 15 studies showed a decreased mortality rate in the terlipressin group (4 of them were significant).Conclusion This review showed that terlipressin has a significantly higher reversal rate of HRS than the other treatments. …”
    Get full text
    Article
  4. 564

    The efficacy of parasacral transcutaneous electrical nerve stimulation for the treatment of overactive bladder in children: a systematic review and meta-analysis by Zhuoqi Cheng, Yumeng Chai, Zhongbao Zhou, Yong Zhang

    Published 2025-01-01
    “…From the literature review, eight RCTs (351 participants) comparing PTENS and other treatments (standard urotherapy/anticholinergics/biofeedback/placebo stimulation) were considered.ResultsThe overall complete response rate with PTENS was 1.90 times that of children undergoing other treatment (relative risk 1.90, 95% confidence interval 1.45–2.49). …”
    Get full text
    Article
  5. 565

    Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER st... by M. V. Mayevskaya, V. T. Ivashkin, O. O. Znoyko, Ye. A. Klimova, D. T. Abdurakhmanov, I. G. Bakulin, P. O. Bogomolov, E. Z. Burnevich, M. Yu. Galushko, N. I. Geyvandova, K. V. Zhdanov, Ye. V. Esaulenko, S. N. Kizhlo, D. Yu. Konstantinov, N. I. Mironova, V. G. Morozov, Ye. A. Strebkova, I. G. Nikitin, M. F. Osipenko, V. D. Pasechnikov, O. I. Sagalova, I. M. Khayertynova, V. P. Chulanov, A. A. Yakovlev, I. A. Vasyutin, Ye. P. Tarkhova, E. N. Krasavina, M. Yu. Samsonov

    Published 2018-08-01
    “…To estimate efficacy and safety of narlaprevir (NVR) with ritonavir (RTV), pegilated interferon (peg-IFN) and ribavirin (RBV) at treatmentnaïve and earlier treated noncirrhotic patients with chronic hepatitis C caused by the 1st virus genotype in double blind placebo-controlled 3rd phase study (PIONEER). Material and methods. …”
    Get full text
    Article
  6. 566

    Evaluation of long‐acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084 by Sinead Delany‐Moretlwe, Brett Hanscom, Xu Guo, Clemensia Nkabiito, Patricia Mandima, Patricia Ntege Nahirya, Juliet Mpendo, Muchaneta Bhondai‐Mhuri, Nyaradzo Mgodi, Rebecca Berhanu, Jennifer Farrior, Estelle Piwowar‐Manning, Susan L. Ford, Craig W. Hendrix, Alex R. Rinehart, James F. Rooney, Adeola Adeyeye, Raphael J. Landovitz, Myron S. Cohen, Mina C. Hosseinipour, Mark A. Marzinke, the HPTN 084 Study Team

    Published 2025-01-01
    “…Methods Participants were randomized 1:1 to either active cabotegravir (CAB) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) placebo or active TDF/FTC plus CAB placebo. Pregnancy testing was performed at each visit; participants with a positive test had study product withheld and were offered open‐label TDF/FTC. …”
    Get full text
    Article
  7. 567

    Ethanolic extract of black soldier fly (Hermetia illucens L.) larvae for wound healing in mice (Mus musculus L.) by Darman Agung Sandakila, Gracetia Devita Hadi, Riska Gultom, Seni Samalele, Rudy Agung Nugroho

    Published 2024-12-01
    “…Using a completely randomized design, 30 male mice were divided into 6 treatment groups: no treatment (K-1), placebo (K-2), povidone iodine 10% (K+), and BSFL ethanolic extract at 10%, 15%, and 20% concentrations. …”
    Get full text
    Article
  8. 568

    Response Rate and Impact on Lipid Profiles of Obeticholic Acid Treatment for Patients with Primary Biliary Cholangitis: A Meta-Analysis by Yuan Gao, Li Li, Bei Li, Yutao Zhan

    Published 2021-01-01
    “…Three trials, with 265 patients, were selected for the analysis. OCA was superior to placebo in PBC patients (RR, 1.48; 95% CI, 1.15–1.90). …”
    Get full text
    Article
  9. 569

    The effect of gonadotropin-releasing hormone or human chorionic gonadotropin administration at mating on lambing performance in konya merino yearling ewes by Mehmet Köse, Ahmet Hamdi Aktaş, Mesut Kırbaş, Bülent Bülbül

    “…Group I (n=14) were injected 200 IU hCG, Group II (n=12) were injected 4 μg GnRH, and Group III (control group, n=10) were injected 1 mL placebo at mating. Pregnancy was diagnosed on day 30 by using transrectal ultrasonography.…”
    Get full text
    Article
  10. 570

    The Effect of Vitamin D Supplementation on Blood Lipids in Patients with Polycystic Ovary Syndrome: A Meta-Analysis of Randomized Controlled Trials by Hong Gao, YanTao Li, WenNan Yan, Fei Gao

    Published 2021-01-01
    “…The results of the meta-analysis showed that, compared with placebo, vitamin D supplementation can significantly reduce total cholesterol level (WMD = –11.32, 95% CI = [–14.51, –8.41], P<0.00001), low-density lipoprotein cholesterol level (WMD = –4.83, 95% CI = [–7.52, –2.14], P=0.0004), and triglyceride level (WMD = –8.23, 95% CI = [–13.08, –3.38], P=0.0009, but the effect on high-density lipoprotein cholesterol level is not statistically significant (WMD = –0.32, 95%CI = [–1.24, 0.60], P=0.50). …”
    Get full text
    Article
  11. 571

    Effectiveness of Combination of Chitosan Gel and Hydroxyapatite from Crabs Shells (Portunus pelagicus) Waste as Bonegraft on Periodontal Network Regeneration through IL-1 and BMP-2... by Asdar Gani, Risfah Yulianty, Supiaty Supiaty, Machirah Rusdy, Gustivanny Dwipa Asri, Dian Eka Satya, Ayu Rahayu Feblina, Harun Achmad

    Published 2022-01-01
    “…Then the femoral bone defect was made, the positive control group was given placebo gel, the positive control group was given BATAN hydroxyapatite, and the test group was given a combination of chitosan gel and hydroxyapatite crab shells. …”
    Get full text
    Article
  12. 572

    Effects of Meaningful Action Observation Therapy on Occupational Performance, Upper Limb Function, and Corticospinal Excitability Poststroke: A Double-Blind Randomized Control Tria... by Aryan Shamili, Afsoon Hassani Mehraban, Akram Azad, Gholam Reza Raissi, Mohsen Shati

    Published 2022-01-01
    “…Instead, patients in the control group watched nature videos as a placebo. Clinical outcomes were evaluated using the Canadian Occupational Performance Measure (COPM), Fugl-Meyer Assessment (FMA), Action Research Arm Test (ARAT), and Box-Block Test (BBT) on 3 occasions: baseline, post (at 4 weeks), and follow-up (at 8 weeks). …”
    Get full text
    Article
  13. 573

    Continuous Exercise but Not High Intensity Interval Training Improves Fat Distribution in Overweight Adults by Shelley E. Keating, Elizabeth A. Machan, Helen T. O'Connor, James A. Gerofi, Amanda Sainsbury, Ian D. Caterson, Nathan A. Johnson

    Published 2014-01-01
    “…The purpose of this study was to assess the effect of high intensity interval training (HIIT) versus continuous aerobic exercise training (CONT) or placebo (PLA) on body composition by randomized controlled design. …”
    Get full text
    Article
  14. 574

    The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review. by Rasha Alkholy, Karina Lovell, Penny Bee, Rebecca Pedley, Helen Louise Brooks, Richard J Drake, Prathiba Chitsabesan, Anam Bhutta, Abigail Brown, Rebecca L Jenkins, Andrew Grundy

    Published 2025-01-01
    “…Given the lack of direct evidence from high-quality placebo-controlled trials, it is pertinent to interpret the quantitative findings with caution. …”
    Get full text
    Article
  15. 575

    Functional Near-Infrared Spectroscopy to Probe State- and Trait-Like Conditions in Chronic Tinnitus: A Proof-of-Principle Study by Martin Schecklmann, Anette Giani, Sara Tupak, Berthold Langguth, Vincent Raab, Thomas Polak, Csanád Várallyay, Wilma Harnisch, Martin J. Herrmann, Andreas J. Fallgatter

    Published 2014-01-01
    “…Twenty-three patients received continuous theta burst stimulation over the left primary auditory cortex in a randomized sham-controlled neuronavigated trial (verum = 12; placebo = 11). Before and after treatment, sound-evoked brain oxygenation in temporal areas was measured with fNIRS. …”
    Get full text
    Article
  16. 576

    Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery: A Randomized Controlled Study by Cattleya Thongrong, Patitha Chullabodhi, Pornthep Kasemsiri, Amnat Kitkhuandee, Narin Plailaharn, Lumyai Sabangban, Thirada Jimarsa

    Published 2018-01-01
    “…D) received intraoperative dexamethasone 4 mg iv and ondansetron 4 mg iv, whereas the control group (Gr. N) received placebo (0.9% normal saline 1 ml iv and 0.9% normal saline 2 ml iv). …”
    Get full text
    Article
  17. 577

    Clinical Efficacy of Probiotic Therapy on Bowel-Related Symptoms in Patients with Ulcerative Colitis during Endoscopic Remission: An Observational Study by Jin Lee, Su Bum Park, Hyung Wook Kim, Hong Sub Lee, Sam Ryong Jee, Jong Hun Lee, Tae Oh Kim

    Published 2022-01-01
    “…As this is an observational study and has no placebo-controlled arm, further prospective randomized controlled trials are needed to confirm these results.…”
    Get full text
    Article
  18. 578

    Long-term cardiac MRI follow up of MANTICORE (Multidisciplinary Approach to Novel Therapies in Cardio-Oncology REsearch) by Dina Labib, Mark Haykowsky, Emer Sonnex, John R. Mackey, Richard B. Thompson, D. Ian Paterson, Edith Pituskin

    Published 2025-02-01
    “…Results We found that, contrary to the hypothesis, participants maintained LV EF over the follow-up period. Specifically, the placebo group exhibited a recovery in LV EF to levels comparable with the treatment groups, suggesting no long-term differential impact on cardiac function. …”
    Get full text
    Article
  19. 579

    Relationships of dermatologic symptoms and quality of life in patients with psoriatic arthritis: analysis of two tofacitinib phase III studies by Peter C. Taylor, Andrew G. Bushmakin, Joseph C. Cappelleri, Pamela Young, Rebecca Germino, Joseph F. Merola, Gil Yosipovitch

    Published 2022-07-01
    “…Objectives Evaluate relationships between changes in dermatologic assessments and quality of life (QoL) measures; quantify dermatologic symptom severity impacts on QoL in patients with psoriatic arthritis (PsA) treated with tofacitinib.Methods Data were from two phase III studies; patients received tofacitinib 5 or 10 mg twice daily (BID), adalimumab 40 mg every other week, or placebo advancing to tofacitinib 5 or 10 mg BID at Month 3. …”
    Get full text
    Article
  20. 580

    The Levels of Tumor Necrosis Factor-Alpha and Interleukin-6 in Patients with Isolated Coronary Artery Ectasia by Mustafa Aydin, Ishak Ozel Tekin, Sait Mesut Dogan, Nesligul Yildirim, Mehmet Arasli, Muhammet Rasit Sayin, Ziyaettin Aktop

    Published 2009-01-01
    “…This study provides evidence for alterations in the proinflamatory cytokines which suggest the involvement of the immune system in the pathophysiology of CAE. Further placebo-controlled studies are needed to evaluate the clinical significance of this increase in TNF-𝛼 and IL-6 levels.…”
    Get full text
    Article